Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Inhibition of virus-induced neuronal apoptosis by Bax

Abstract

The Bax protein is widely known as a pro-apoptotic Bcl-2 family member that when overexpressed can trigger apoptosis in multiple cell types and is important for the developmental cell death of neurons1,2. However, Bax was found here to be a potent inhibitor of neuronal cell death in mice infected with Sindbis virus. Newborn mice, which are highly susceptible to a fatal infection with neurotropic Sindbis virus, were significantly protected from neuronal apoptosis and fatal disease when infected with a recombinant Sindbis virus encoding Bax. Deletion of the N terminus of Bax, which mimics cleaved Bax, converted Bax into a pro-apoptotic factor in vivo. As mice mature during the first week after birth, they acquire resistance to a fatal Sindbis virus infection3,4. However, Bax-deficient mice remained very sensitive to fatal disease compared with their control littermates, indicating that endogenous Bax functions as a survival factor and contributes to age-dependent resistance to Sindbis virus-induced mortality. The protective effects of Bax were reproduced in cultured hippocampal neurons but not in cultured dorsal root ganglia neurons. These findings indicate that cell-specific factors determine the anti-apoptotic versus pro-apoptotic function of Bax.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Overexpression of Bax protects mice from a fatal Sindbis virus infection.
Figure 2: Mice deficient in bax show increased neuronal apoptosis and increased susceptibility to a fatal Sindbis virus infection.
Figure 3: Tissue sections from brains of bax+/+ and bax–/– mice 4 d after infection with SV-Bax-reverse.
Figure 4: Neuron-specific function of Bax.

Similar content being viewed by others

References

  1. Deckwerth, T.L. et al. Bax is required for neuronal death after trophic factor deprivation and during development. Neuron 17, 401–411 (1996).

    Article  CAS  Google Scholar 

  2. White, F.A., Keller-Peck, C.R., Knudson, C.M., Korsmeyer, S.J. & Snider, W.D. Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18, 1428–1439 (1998).

    Article  CAS  Google Scholar 

  3. Lewis, J., Wesselingh, S.L., Griffin, D.E. & Hardwick, J.M. Sindbis virus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70, 1828–1835 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Hardwick, J.M., Irani, D.N. & Griffin, D.E. in Cell Death in Diseases of the Nervous System (eds. Koliatsos, V.E. & Ratan, R.) 295–323 (Humana Press, Totowa, New Jersey, 1999).

    Book  Google Scholar 

  5. Middleton, G., Nunez, G. & Davies, A.M. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors. Development 122, 695–701 (1996).

    CAS  PubMed  Google Scholar 

  6. Oh, J.H., O'Malley, K.L., Krajewski, S., Reed, J.C. & Oh, Y.J. Bax accelerates staurosporine-induced but suppresses nigericin-induced neuronal cell death. Neuroreport 8, 1851–1856 (1998).

    Article  Google Scholar 

  7. Zhou, M., Demo, S.D., McClure, T.N., Crea, R. & Bitler, C.M. A novel splice variant of the cell death-promoting protein BAX. J. Biol. Chem. 273, 11930–11936 (1998).

    Article  CAS  Google Scholar 

  8. Cheng, E.H.-Y., Levine, B., Boise, L.H., Thompson, C.B. & Hardwick, J.M. Bax-independent inhibition of apoptosis by Bcl-xL. Nature 379, 554–556 (1996).

    Article  CAS  Google Scholar 

  9. Levine, B., Goldman, J.E., Jiang, H.H., Griffin, D.E. & Hardwick, J.M. Bcl-2 protects mice against fatal alphavirus encephalitis. Proc. Natl. Acad. Sci. USA 93, 4810–4815 (1996).

    Article  CAS  Google Scholar 

  10. Levine, B. et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361, 739–742 (1993).

    Article  CAS  Google Scholar 

  11. Ubol, S., Tucker, P.C., Griffin, D.E. & Hardwick, J.M. Neurovirulent strains of alphavirus induce apoptosis in bcl-2-expressing cells; Role of a single amino acid change in the E2 glycoprotein. Proc. Natl. Acad. Sci. USA 91, 5202–5206 (1994).

    Article  CAS  Google Scholar 

  12. Hunter, J.J., Bond, B.L. & Parslow, T.G. Functional dissection of the human Bcl-2 protein: sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16, 877–883 (1996).

    Article  CAS  Google Scholar 

  13. Cheng, E.H.-Y. et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966–1968 (1997).

    Article  CAS  Google Scholar 

  14. Clem, R. J. et al. Modulation of cell death by Bcl-xL through caspase interaction. Proc. Natl. Acad. Sci. USA 95, 554–559 (1998).

    Article  CAS  Google Scholar 

  15. Yoshida, H. et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94, 739–750 (1998).

    Article  CAS  Google Scholar 

  16. Kuida, K. et al. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325–337 (1998).

    Article  CAS  Google Scholar 

  17. Chou, J.J., Li, H., Salvesen, G., Yuan, J. & Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96, 615–624 (1999).

    Article  CAS  Google Scholar 

  18. McDonnell, J.M., Fushman, D., Milliman, C.L., Korsmeyer, S.J. & Cowburn, D. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625–634 (1999).

    Article  CAS  Google Scholar 

  19. Thomas, A. et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12, 1055–1062 (1996).

    CAS  PubMed  Google Scholar 

  20. Grandgirard, D. et al. Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 17, 1268–1278 (1998).

    Article  CAS  Google Scholar 

  21. Wood, D.E. et al. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene 17, 1069–1078 (1998).

    Article  CAS  Google Scholar 

  22. Kirsch, D.G. et al. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c. J. Biol. Chem. (in the press).

  23. Wolter, K.G. et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell. Biol. 139, 1281–1292 (1997).

    Article  CAS  Google Scholar 

  24. Kiefer, M.C. et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736–739 (1995).

    Article  CAS  Google Scholar 

  25. Vornov, J.J., Tasker, R.C. & Park, J. Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures. Exp. Neurol. 133, 7–17 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by research grant NS34175 (J.M.H.) from the National Institutes of Health and a career development award from the Burroughs Wellcome Foundation (G.A.O.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Marie Hardwick.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, J., Oyler, G., Ueno, K. et al. Inhibition of virus-induced neuronal apoptosis by Bax. Nat Med 5, 832–835 (1999). https://doi.org/10.1038/10556

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/10556

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing